EUVIMEDEUVIMED entdecken
Crossref

A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID‐19 pandemic

Therese Boyle iD, Reina Zaragoza, Jamma Li, Vera Cvetanovski, Phillippa Weaver, Philip Hoyle, Venkatesha Venkatesha, Suran L Fernando

Internal Medicine Journal · 2023

DOI: 10.1111/imj.16104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Therese Boyle und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Department, Level 3, ASB, Royal North Shore Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: COVID-19, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Forty‐four of 50 immunology patients with primary or secondary immunodeficiency receiving intravenous immunoglobulin at a hospital in New South Wales, Australia, were rapidly enrolled in the subcutaneous immunoglobulin (SCIg) programme at the onset of the 2020 COVID‐19 pandemic. Health and economic outcomes demonstrated that SCIg provides clinical efficacy as evidenced by the number of infections and maintenance of IgG levels, and also facilitates cost reduction in immunoglobulin maintenance programmes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunologic Deficiency SyndromesHumansImmunoglobulins, IntravenousRetrospective StudiesPandemics

Stichwörter der Autor:innen

economicimmunodeficienciesimmunoglobulinpandemic

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Clinical Immunology Department, Level 3, ASB, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Immunology Laboratory, Level 5, ASB, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • School of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Patient Safety and Quality Unit, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Department of Medical Services, ASB, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Northern Sydney Local Health District Executive, Sydney, New South Wales, Australia.

ORCID-Profile: Therese Boyle

Zitieren

APA

Boyle, T., Zaragoza, R., Li, J., Cvetanovski, V., Weaver, P., Hoyle, P., Venkatesha, V., & Fernando, S. L. (2023). A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID‐19 pandemic. Internal Medicine Journal. https://doi.org/10.1111/imj.16104

Vancouver

Boyle T, Zaragoza R, Li J, Cvetanovski V, Weaver P, Hoyle P, et al. A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID‐19 pandemic. Internal Medicine Journal. 2023. doi:10.1111/imj.16104

BibTeX
@article{Boyle2023,
  author = {Boyle, Therese and Zaragoza, Reina and Li, Jamma and Cvetanovski, Vera and Weaver, Phillippa and Hoyle, Philip and Venkatesha, Venkatesha and Fernando, Suran L},
  title = {A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID‐19 pandemic},
  journal = {Internal Medicine Journal},
  year = {2023},
  doi = {10.1111/imj.16104}
}
Kostenlos starten →